TY - JOUR
T1 - The Collaborative Ocular Tuberculosis Study (COTS)-1
T2 - A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population
AU - Testi, Ilaria
AU - Agrawal, Rupesh
AU - Mahajan, Sarakshi
AU - Agarwal, Aniruddha
AU - Gunasekeran, Dinesh Visva
AU - Raje, Dhananjay
AU - Aggarwal, Kanika
AU - Murthy, Somasheila I.
AU - Westcott, Mark
AU - Chee, Soon Phaik
AU - Mccluskey, Peter
AU - Ho, Su Ling
AU - Teoh, Stephen
AU - Cimino, Luca
AU - Biswas, Jyotirmay
AU - Narain, Shishir
AU - Agarwal, Manisha
AU - Mahendradas, Padmamalini
AU - Khairallah, Moncef
AU - Jones, Nicholas
AU - Tugal-Tutkun, Ilknur
AU - Babu, Kalpana
AU - Basu, Soumayava
AU - Carreño, Ester
AU - Lee, Richard
AU - Al-Dhibi, Hassan
AU - Bodaghi, Bahram
AU - Invernizzi, Alessandro
AU - Goldstein, Debra A.
AU - Herbort, Carl P.
AU - Barisani-Asenbauer, Talin
AU - González-López, Julio J.
AU - Androudi, Sofia
AU - Bansal, Reema
AU - Moharana, Bruttendu
AU - Esposti, Simona Degli
AU - Tasiopoulou, Anastasia
AU - Nadarajah, Sengal
AU - Agarwal, Mamta
AU - Abraham, Sharanaya
AU - Vala, Ruchi
AU - Singh, Ramandeep
AU - Sharma, Aman
AU - Sharma, Kusum
AU - Zierhut, Manfred
AU - Kon, Onn Min
AU - Cunningham, Emmett T.
AU - Kempen, John H.
AU - Nguyen, Quan Dong
AU - Pavesio, Carlos
AU - Gupta, Vishali
N1 - Publisher Copyright:
© 2020 Taylor & Francis Group, LLC.
PY - 2020
Y1 - 2020
N2 - Purpose: To examine disease profile of tubercular uveitis (TBU) in Paediatric population. Methods: Among 945 patients of the retrospective multinational study by the Collaborative Ocular Tuberculosis Study (COTS)-1, 29 Paediatric patients diagnosed with TBU were analyzed. Results: Mean age of disease presentation was 12.8 (range 4–18 years), with predominance of males (n = 14/20; 70.0%) and Asian ethnicity (n = 25/29; 86.2%). Posterior uveitis (n = 14/28; 50%) was the most frequent uveitis phenotype, with choroidal involvement occurring in 64.7% (n = 11/17). Incidence of optic disc edema and macular edema was higher in children (n = 8/18; 44.4% and n = 5/18; 27.8%, respectively) than in adults (n = 160/942; 16.9% and n = 135/942; 14.3%, respectively). Comparison of optic disc edema between subgroups showed a significant difference (P =.006). All patients received oral corticosteroids, most of them with antitubercular therapy. Treatment failure developed in 4.8% (n = 1/21). Conclusions: Children have a more severe inflammatory response to the disease, and an intensive anti-inflammatory therapeutic regimen is required to achieve a positive treatment outcome.
AB - Purpose: To examine disease profile of tubercular uveitis (TBU) in Paediatric population. Methods: Among 945 patients of the retrospective multinational study by the Collaborative Ocular Tuberculosis Study (COTS)-1, 29 Paediatric patients diagnosed with TBU were analyzed. Results: Mean age of disease presentation was 12.8 (range 4–18 years), with predominance of males (n = 14/20; 70.0%) and Asian ethnicity (n = 25/29; 86.2%). Posterior uveitis (n = 14/28; 50%) was the most frequent uveitis phenotype, with choroidal involvement occurring in 64.7% (n = 11/17). Incidence of optic disc edema and macular edema was higher in children (n = 8/18; 44.4% and n = 5/18; 27.8%, respectively) than in adults (n = 160/942; 16.9% and n = 135/942; 14.3%, respectively). Comparison of optic disc edema between subgroups showed a significant difference (P =.006). All patients received oral corticosteroids, most of them with antitubercular therapy. Treatment failure developed in 4.8% (n = 1/21). Conclusions: Children have a more severe inflammatory response to the disease, and an intensive anti-inflammatory therapeutic regimen is required to achieve a positive treatment outcome.
KW - Collaborative Ocular Tuberculosis Study (COTS)
KW - Ocular tuberculosis
KW - children
KW - pediatric population
KW - tubercular uveitis
UR - http://www.scopus.com/inward/record.url?scp=85089536911&partnerID=8YFLogxK
U2 - 10.1080/09273948.2020.1781197
DO - 10.1080/09273948.2020.1781197
M3 - Article
C2 - 32804578
AN - SCOPUS:85089536911
SN - 0927-3948
VL - 28
SP - 58
EP - 64
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - sup1
ER -